These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20653146)

  • 1. Parkinson's disease and look-alikes.
    Khadilkar SV
    J Assoc Physicians India; 2010 Feb; 58():75. PubMed ID: 20653146
    [No Abstract]   [Full Text] [Related]  

  • 2. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Red flags": when to be alerted and how to explore?].
    Tison F
    Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Tong J; Fitzmaurice PS; Ang LC; Furukawa Y; Guttman M; Kish SJ
    Ann Neurol; 2004 Jan; 55(1):125-9. PubMed ID: 14705122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic criteria for Parkinson syndromes, expecting Parkinson's disease].
    Vidailhet M
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():43-50. PubMed ID: 10916036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].
    Vercueil L
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():14-22. PubMed ID: 10916032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy.
    Rascol OJ; Clanet M; Senard JM; Montastruc JL; Rascol A
    Adv Neurol; 1993; 60():395-7. PubMed ID: 8420160
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis of Parkinson's disease: current consensus criteria and outlook].
    Respondek G; Decker S; Steinmeyer L; Oertel WH; Höglinger GU
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S8-15. PubMed ID: 20195943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical Parkinson syndromes].
    Strzelczyk A; Möller JC; Stamelou M; Matusch A; Oertel WH
    Nervenarzt; 2008 Oct; 79(10):1203-20; quiz 1221-2. PubMed ID: 18751965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference?
    Esterhammer R; Schocke M; Seppi K
    Eur J Neurol; 2010 Sep; 17(9):1111-1112. PubMed ID: 20561041
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid Abeta42 levels in multiple system atrophy.
    Verbeek MM; Abdo WF; De Jong D; Horstink MW; Kremer BP; Bloem BR
    Mov Disord; 2004 Feb; 19(2):238-40; author reply 240-1. PubMed ID: 14978688
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A; DeNotaris R
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Leiguarda R; Merello M; Balej J; Starkstein S; Nogues M; Marsden CD
    Mov Disord; 2000 Jul; 15(4):627-40. PubMed ID: 10928572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study.
    Avenali M; Tassorelli C; De Icco R; Perrotta A; Serrao M; Fresia M; Pacchetti C; Sandrini G
    Clin Neurophysiol; 2017 Oct; 128(10):1978-1984. PubMed ID: 28829981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.